These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 23355652)
1. Cardiac resynchronization therapy: state of the art 2013. Yu CM; Hayes DL Eur Heart J; 2013 May; 34(19):1396-403. PubMed ID: 23355652 [TBL] [Abstract][Full Text] [Related]
2. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC; Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578 [TBL] [Abstract][Full Text] [Related]
3. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424 [TBL] [Abstract][Full Text] [Related]
4. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation. Rönn F; Kesek M; Karp K; Henein M; Jensen SM Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261 [TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronisation therapy in patients with chronic heart failure. Lalani GG; Birgersdotter-Green U Heart; 2015 Jul; 101(13):1008-14. PubMed ID: 25882504 [TBL] [Abstract][Full Text] [Related]
6. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial. Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239 [TBL] [Abstract][Full Text] [Related]
7. Biventricular paced QRS predictors of left ventricular lead locations in relation to mortality in cardiac resynchronization therapy. Fontaine JM; Gupta A; Franklin SM; Kang CU; Whigham LA J Electrocardiol; 2015; 48(2):226-35. PubMed ID: 25552478 [TBL] [Abstract][Full Text] [Related]
8. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy. Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673 [TBL] [Abstract][Full Text] [Related]
9. Implantation of left ventricular epicardial leads in cardiosurgical patients with impaired cardiac function--a worthwhile procedure in concomitant surgical interventions? Mellert F; Schneider C; Esmailzadeh B; Balta O; Haushofer M; Schiller W; Preusse CJ; Welz A Thorac Cardiovasc Surg; 2012 Feb; 60(1):64-9. PubMed ID: 21425053 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure. Freeman JV; Masoudi FA Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318 [TBL] [Abstract][Full Text] [Related]
11. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. Stevenson WG; Hernandez AF; Carson PE; Fang JC; Katz SD; Spertus JA; Sweitzer NK; Tang WH; Albert NM; Butler J; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Givertz MM; Hershberger RE; Rogers JG; Teerlink JR; Walsh MN; Stough WG; Starling RC; J Card Fail; 2012 Feb; 18(2):94-106. PubMed ID: 22300776 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of two surgical alternatives for cardiac resynchronization therapy: trans-apical versus epicardial left ventricular pacing. Mihalcz A; Kassai I; Kardos A; Foldesi C; Theuns D; Szili-Torok T Pacing Clin Electrophysiol; 2012 Feb; 35(2):124-30. PubMed ID: 22017475 [TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy: current trends and future directions. Jacob S; Bharadwaj AS; Panaich SS; Mathew A; Afonso L Minerva Cardioangiol; 2010 Dec; 58(6):717-29. PubMed ID: 21135811 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC; Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898 [TBL] [Abstract][Full Text] [Related]